Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
384.0000 -2.80 (-0.72%)
NSE Sep 10, 2026 15:31 PM
Volume: 187.7K
 

384.00
-0.72%
GEPL Capital
Syngene International ltd. (SIL) Limited is one of India's leading contract research company. SIL is founded in 1993 and a subsidiary of Biocon Ltd. Syngene is a leading custom research and manufacturing organization, which supports R&D; programs from lead generation to clinical supplies. The company's multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, toxicology, custom synthesis, process R&D;, cGMP manufacturing, formulation and analytical development. The company provides significant cost advantage to companies seeking to minimize their R&D; spends. The lower cost structure in Asia Pacific region helps in reducing R&D; spend by...
Syngene Intl has lost -40.43% in the last 1 Year
More from Syngene International Ltd.
Recommended